Principal Financial Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-22,759
| Closed | -$38.2K | – | 2327 |
|
|
2024
Q2 | $38.2K | Buy |
22,759
+12,225
| +116% | +$21.9K | ﹤0.01% | 2305 |
|
|
2024
Q1 | $25.3K | Hold |
10,534
| – | – | ﹤0.01% | 2393 |
|
|
2023
Q4 | $16.1K | Buy |
10,534
+201
| +2% | +$239 | ﹤0.01% | 2392 |
|
|
2023
Q3 | $11.3K | Hold |
10,333
| – | – | ﹤0.01% | 2428 |
|
|
2023
Q2 | $23.7K | Sell |
10,333
-30,211
| -75% | -$80.2K | ﹤0.01% | 2404 |
|
|
2023
Q1 | $98.5K | Sell |
40,544
-667
| -2% | -$1.53K | ﹤0.01% | 2300 |
|
|
2022
Q4 | $78.7K | Buy |
41,211
+31,205
| +312% | +$66.4K | ﹤0.01% | 2332 |
|
|
2022
Q3 | $24K | Buy |
+10,006
| New | +$27.7K | ﹤0.01% | 2449 |
|
|
2022
Q2 | – | Sell |
-51,855
| Closed | -$108K | – | 2592 |
|
|
2022
Q1 | $108K | Sell |
51,855
-18,934
| -27% | -$52.5K | ﹤0.01% | 2419 |
|
|
2021
Q4 | $279K | Sell |
70,789
-122,623
| -63% | -$596K | ﹤0.01% | 2264 |
|
|
2021
Q3 | $930K | Sell |
193,412
-5,870
| -3% | -$24.1K | ﹤0.01% | 2022 |
|
|
2021
Q2 | $915K | Buy |
199,282
+17,420
| +10% | +$83.9K | ﹤0.01% | 2060 |
|
|
2021
Q1 | $1.07M | Buy |
181,862
+13,226
| +8% | +$91.6K | ﹤0.01% | 1982 |
|
|
2020
Q4 | $577K | Buy |
168,636
+37,201
| +28% | +$71K | ﹤0.01% | 2081 |
|
|
2020
Q3 | $189K | Buy |
131,435
+62,196
| +90% | +$111K | ﹤0.01% | 2217 |
|
|
2020
Q2 | $138K | Buy |
+69,239
| New | +$136K | ﹤0.01% | 2228 |
|
|
2019
Q4 | – | Sell |
-15,765
| Closed | -$47K | – | 2258 |
|
|
2019
Q3 | $47K | Sell |
15,765
-509
| -3% | -$1.58K | ﹤0.01% | 2214 |
|
|
2019
Q2 | $102K | Buy |
16,274
+603
| +4% | +$3.61K | ﹤0.01% | 2181 |
|
|
2019
Q1 | $87K | Buy |
15,671
+478
| +3% | +$2.9K | ﹤0.01% | 2160 |
|
|
2018
Q4 | $101K | Sell |
15,193
-1,089
| -7% | -$8.82K | ﹤0.01% | 2176 |
|
|
2018
Q3 | $174K | Buy |
16,282
+773
| +5% | +$8.86K | ﹤0.01% | 2188 |
|
|
2018
Q2 | $186K | Sell |
15,509
-3,468
| -18% | -$35.5K | ﹤0.01% | 2175 |
|
|
2018
Q1 | $163K | Buy |
18,977
+1,680
| +10% | +$15.5K | ﹤0.01% | 2128 |
|
|
2017
Q4 | $171K | Buy |
+17,297
| New | +$180K | ﹤0.01% | 2152 |
|
|
2017
Q2 | – | Sell |
-22,684
| Closed | -$325K | – | 2275 |
|
|
2017
Q1 | $325K | Buy |
22,684
+70
| +0.3% | +$1.04K | ﹤0.01% | 1989 |
|
|
2016
Q4 | $313K | Buy |
+22,614
| New | +$363K | ﹤0.01% | 2004 |
|
|
2015
Q3 | – | Sell |
-11,065
| Closed | -$89K | – | 2204 |
|
|
2015
Q2 | $89K | Buy |
+11,065
| New | +$81.3K | ﹤0.01% | 2141 |
|
|
2015
Q1 | – | Sell |
-8,559
| Closed | -$55K | – | 2184 |
|
|
2014
Q4 | $55K | Buy |
+8,559
| New | +$69K | ﹤0.01% | 2149 |
|
|
2014
Q1 | – | Sell |
-15,290
| Closed | -$193K | – | 2291 |
|
|
2013
Q4 | $193K | Buy |
+15,290
| New | +$243K | ﹤0.01% | 2159 |
|
Other funds holding LXRX
AG
SL
O
NMC
